LNSR Q3 2021 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$141M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+15.8% YoY

Gross Profit

$4M46.6% margin

Operating Income

-$6M-74.5% margin

Net Income

-$6M-74.4% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$68M

Total Liabilities

$11M

Stockholders' Equity

$57M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+15.8%
Gross Profit	$4M	$4M	-1.2%
Operating Income	-$6M	-$5M	-30.8%
Net Income	-$6M	-$5M	-29.2%

Revenue Segments

Product

$6M87%

Service

$903,00013%

Geographic Segments

U S

$4M50%

Asia Excluding South Korea

$1M18%

K R

$1M17%

Europe

$908,00013%

Other Geographical Region

$115,0002%